XML 25 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Assets    
Fixed maturities, available for sale, at fair value (amortized cost $88,277 and $81,781; allowance for expected credit losses of $2 and $5) $ 83,666 $ 77,807
Equity securities, at fair value (cost $544 and $553) 687 608
Real estate investments 902 959
Short-term securities 4,766 5,137
Other investments 4,202 4,299
Total investments 94,223 88,810
Cash (including restricted cash of $131 and $150) 699 650
Investment income accrued 752 688
Premiums receivable (net of allowance for expected credit losses of $58 and $69) 11,110 10,282
Reinsurance recoverables (net of allowance for estimated uncollectible reinsurance of $119 and $118) 8,000 8,143
Ceded unearned premiums 1,202 1,150
Deferred acquisition costs 3,494 3,306
Deferred taxes 1,762 1,504
Contractholder receivables (net of allowance for expected credit losses of $18 and $20) 3,171 3,249
Goodwill 4,233 3,976
Other intangible assets 360 277
Other assets 4,183 3,943
Total assets 133,189 125,978
Liabilities    
Claims and claim adjustment expense reserves 64,093 61,627
Unearned premium reserves 22,289 20,872
Contractholder payables 3,189 3,269
Payables for reinsurance premiums 550 518
Debt 8,033 8,031
Other liabilities 7,171 6,740
Total liabilities 105,325 101,057
Shareholders’ equity    
Common stock (1,750.0 shares authorized; 226.6 and 228.2 shares issued and outstanding) 25,452 24,906
Retained earnings 49,630 45,591
Accumulated other comprehensive loss (4,967) (4,471)
Treasury stock, at cost (564.3 and 559.2 shares) (42,251) (41,105)
Total shareholders’ equity 27,864 24,921
Total liabilities and shareholders’ equity $ 133,189 $ 125,978